| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.49▼ | 6.44▲ | 6.44▲ | 6.31▲ | 5.97▲ |
| MA10 | 6.47▲ | 6.42▲ | 6.43▲ | 6.04▲ | 5.26▲ |
| MA20 | 6.43▲ | 6.42▲ | 6.42▲ | 5.98▲ | 4.40▲ |
| MA50 | 6.42▲ | 6.36▲ | 6.09▲ | 5.18▲ | 4.61▲ |
| MA100 | 6.43▲ | 6.05▲ | 6.03▲ | 4.31▲ | 3.50▲ |
| MA200 | 6.42▲ | 6.05▲ | 5.76▲ | 4.53▲ | 3.19▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.009▲ | -0.001▼ | -0.014▼ | 0.016▲ | 0.270▲ |
| RSI | 59.577▲ | 58.566▲ | 63.300▲ | 70.632▲ | 69.260▲ |
| STOCH | 92.179▲ | 64.716 | 54.932 | 72.642 | 85.128▲ |
| WILL %R | -18.519▲ | -17.073▲ | -26.786 | -10.092▲ | -4.361▲ |
| CCI | 68.066 | 167.106▲ | 120.034▲ | 119.895▲ | 122.038▲ |
|
Monday, July 21, 2025 05:00 PM
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia ...
|
|
Wednesday, July 09, 2025 04:30 AM
REDWOOD CITY, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 6.51 | 6.515 | 6.29 | 6.50 | 512,683 |
| 14/08/25 | 6.40 | 6.555 | 6.26 | 6.46 | 446,880 |
| 13/08/25 | 6.24 | 6.61 | 6.20 | 6.47 | 770,078 |
| 12/08/25 | 5.95 | 6.30 | 5.95 | 6.20 | 576,007 |
| 11/08/25 | 5.90 | 6.01 | 5.82 | 5.94 | 562,724 |
| 08/08/25 | 5.58 | 5.85 | 5.54 | 5.81 | 420,647 |
| 07/08/25 | 5.71 | 5.755 | 5.52 | 5.57 | 410,407 |
| 06/08/25 | 5.85 | 5.85 | 5.55 | 5.69 | 586,380 |
| 05/08/25 | 5.91 | 5.97 | 5.77 | 5.86 | 732,639 |
| 04/08/25 | 5.91 | 6.09 | 5.75 | 5.90 | 538,405 |
|
|
||||
|
|
||||
|
|